Levatich Matthew S
Director at EMR; President & CEO at HOG
- Sold, on record
- $10.4M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Feb 10, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale HOGUnusualNov 27, 2012 2012
Sold 95,029 shares at $47.42 ($4.5M)
Levatich Matthew S, President & COO of HDMC
Sold 85.3% of holdings ($5.3M position)16,324 shares leftFiling
- 2 Form 4 sale HOGPlan not statedOct 24, 2013 +331 days
Sold 8,883 shares at $64.10 ($569k)
Levatich Matthew S, President & COO of HDMC
Sold 20.6% of holdings ($2.8M position)34,274 shares leftFiling
- 3 Form 4 sale HOGUnusualMay 12, 2014 +200 days
Sold 47,720 shares at $73.19 ($3.5M)
Levatich Matthew S, President & COO of HDMC
Sold 54.1% of holdings ($6.5M position)40,527 shares leftFiling
- 4 Form 4 sale HOGPlan not statedOct 25, 2017 +1262 days
Sold 19,447 shares at $48.36 ($940k)
Levatich Matthew S, President & CEO
Sold 21.9% of holdings ($4.3M position)69,199 shares leftFirst sale on recordFiling
- 5 Form 144 notice EMRNoticeFeb 15, 2024 +2304 days
Filed to sell 1,933 shares ($197k)
Levatich Matthew S, Director
No 10b5-1 planFirst sale on recordFiling
- 6 Form 4 sale EMRNo planFeb 15, 2024 same day
Sold 1,933 shares at $105.58 ($204k)
Levatich Matthew S, Director
No 10b5-1 planSold 7.2% of holdings ($2.8M position)24,965 shares leftFirst sale on recordFollows a Form 144Filing
- 7 Form 4 sale EMRNo planFeb 12, 2025 +363 days
Sold 1,867 shares at $125.05 ($233k)
Levatich Matthew S, Director
No 10b5-1 planSold 7.1% of holdings ($3.3M position)24,574 shares leftFiling
- 8 Form 4 sale EMRNo planFeb 10, 2026 +363 days
Sold 1,476 shares at $162.16 ($239k)
Levatich Matthew S, Director
No 10b5-1 planSold 5.7% of holdings ($4.2M position)24,349 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | Feb 12, 2026 | EMR | Director | Form 4 sale | 1,476 | $239k | 5.7% | No plan | SEC |
| Feb 12, 2025 | Feb 13, 2025 | EMR | Director | Form 4 sale | 1,867 | $233k | 7.1% | No plan | SEC |
| Feb 15, 2024 | Feb 16, 2024 | EMR | Director | Form 4 sale | 1,933 | $204k | 7.2% | No plan | SEC |
| Feb 15, 2024 | Feb 15, 2024 | EMR | Director | Form 144 notice | 1,933 | $197k | Notice | SEC | |
| Oct 25, 2017 | Oct 27, 2017 | HOG | President & CEO | Form 4 sale | 19,447 | $940k | 21.9% | Plan not stated | SEC |
| May 12, 2014 | May 14, 2014 | HOG | President & COO of HDMC | Form 4 sale | 47,720 | $3.5M | 54.1% | Unusual | SEC |
| Oct 24, 2013 | Oct 28, 2013 | HOG | President & COO of HDMC | Form 4 sale | 8,883 | $569k | 20.6% | Plan not stated | SEC |
| Nov 27, 2012 | Nov 29, 2012 | HOG | President & COO of HDMC | Form 4 sale | 95,029 | $4.5M | 85.3% | Unusual | SEC |
| Apr 27, 2012 | May 1, 2012 | HOG | President & COO of HDMC | Form 4 sale | 3,314 | $175k | 16.9% | Plan not stated | SEC |